title: Update: the "Contiform" intravaginal device in four sizes for the treatment of stress incontinence.
abstract: The aim of this study was to evaluate the efficacy of the Contiform intravaginal device for stress incontinence after the addition of a fourth size. We offered the device to a cohort of 73 women with a main complaint of stress incontinence but no prolapse. Of the 73 women invited to participate, 65 enrolled, of whom 52 were fitted. Of these 52 women, 37 (71%) completed the study protocol. Outcome measures were the 24-h pad test, St George score, and quality of life tests. Urine loss on pad test was significantly reduced from a median 6.6 g (interquartile range [IQR] = 4.3-22.6) to 2.2 g (IQR = 0.5-8.2; P = 0.0016) after 4 weeks with significant benefit seen on the Incontinence Impact Questionnaire and Urinary Distress Inventory. The insertion technique was quickly learnt, and the device was well tolerated. The recently developed medium/large size of Contiform was used by 6/37 (16%) women.
authors.affiliation: Pelvic Floor Unit, St George Hospital, Gray St, Kogarah, NSW 2217, Australia.
authors.forename: W A
authors.initials: WA
authors.lastname: Allen
authors.forename: H
authors.initials: H
authors.lastname: Leek
authors.forename: A
authors.initials: A
authors.lastname: Izurieta
authors.forename: K H
authors.initials: KH
authors.lastname: Moore
mesh_terms: D000328:Adult; D004867:Equipment Design; D005260:Female; D006801:Humans; D008875:Middle Aged; D010570:Pessaries; D016896:Treatment Outcome; D014550:Urinary Incontinence, Stress / Q000628:therapy*